²¡ÀíѧÃû´Ê½âÊÍ /h/f
&3'h
eB]cPo4gW
1£® ÊÊÓ¦£¨Adaptation£©£ºÖ¸Ï¸°û¡¢×éÖ¯¡¢Æ÷¹ÙºÍ»úÌå¶ÔÓÚ³ÖÐøÐÔµÄÄÚÍâ´Ì¼¤×ö³öµÄ·ÇËðÉËÐÔ·´Ó¦¡£ Qkt
j
2£® ·Ê´ó£¨Hypertrophy£©£ºÏ¸°û¡¢×éÖ¯»òÆ÷¹ÙÌå»ýÔö´ó³ÆΪ·Ê´ó¡£×éÖ¯¡¢Æ÷¹ÙµÄ·Ê´óͨ³£ÊÇÓÉÓÚʵÖÊϸ°ûµÄ·Ê´óËùÖ£¬¿É°éÓÐϸ°ûÊýÁ¿µÄÔö¼Ó (e:@7W)L
3£® ÔöÉú£¨Hyperplasia£©£ºÆ÷¹Ù»ò×éÖ¯µÄʵÖÊϸ°ûÊýÄ¿Ôö¶à³ÆΪÔöÉú¡£ÔöÉú¿ÉÖÂ×éÖ¯¡¢Æ÷¹ÙµÄÌå»ýÔö´ó¡£ x1g0_&F
4£® ήËõ£¨Atrophy£©£ºÊÇÒÑ·¢ÓýÕý³£µÄʵÖÊϸ°û¡¢×éÖ¯»òÆ÷¹ÙµÄÌå»ýËõС£¬Î®ËõµÄÆ÷¹Ù³£°éÓÐϸ°ûÊýÁ¿µÄ¼õÉÙ¡£ |sQC:y>
5£® »¯Éú£¨Metaplasia£©£ºÒ»ÖÖ·Ö»¯³ÉÊìµÄϸ°ûת»¯ÎªÁíÒ»ÖÖ·Ö»¯³ÉÊìµÄÐÔÖÊÏàËƵÄϸ°ûµÄ¹ý³Ì¡£ ?Cg",k '
6£® ÏßÁ£ÌåÉø͸ÐÔÒÆλ£ºÏßÁ£ÌåËðÉ˳£µ¼ÖÂÏßÁ£ÌåÄÚĤ¸ßµ¼µçÐÔͨµÀµÄÐγɣ¬³ÆΪÏßÁ£ÌåÉø͸ÐÔÒÆλ¡£ k!{0ku}]
7£® ×ÔÓÉ»ù£º¾ßÓÐδÅä¶ÔÍâ²ãµç×ӵĻ¯Ñ§»ùÍÅ¡£Ö÷Òª°üÀ¨ôÇ×ÔÓÉ»ù£¨OH¡££©¡¢È«ôÇ×ÔÓÉ»ù£¨HO2¡££©¡¢³¬ÑõÀë×Ó£¨O2-£©¡¢CCl3¡£×ÔÓÉ»ùºÍ²»ÊôÓÚ×ÔÓÉ»ùµÄ¹ýÑõ»¯Ç⣨H2O2£©¡£Ç°ÈýÕß³ÆΪ»îÐÔÑõ»ùÍÅ¡£ \v7->Sy8
8£® ËèÇÊÑù½á¹¹£¨Myelin figure£©£ºÊÇָϸ°ûÖÊĤºÍ/»òϸ°ûÆ÷Ĥ֬ÖÊƬ¶ÏµÄÂÝÐý×´»òͬÐÄÔ²²ã×´¾íÇú¡£¼ûÓÚϸ°û²»¿ÉÄæËðÉË¡£ 6 WD(
9£® ϸ°ûË®Ö×£¨cellular swelling£©£º»ò³ÆË®±äÐÔ£¨hydropic degeneration£©£¬ÊÇϸ°ûËðÉËÖÐ×îÔç³öÏֵIJ¡±ä£¬ÏµÒòÏßÁ£ÌåÊÜËðATPÉú³É¼õÉÙ£¬Ï¸°ûĤNa+-K+±Ã¹¦ÄÜÕÏ°¶øµ¼ÖÂϸ°ûÄÚÄÆÀë×ÓºÍË®µÄ¹ý¶à»ý¾Û¡£³£¼ûÓÚȱÑõ¡¢¸ÐȾ¡¢Öж¾Ê±ÐÄ¡¢¸Î¡¢ÉöµÈÆ÷¹ÙµÄʵÖÊϸ°û¡£ ~EYsUC#B_
9£® Ö¬·¾±ä£¨Fatty change£©£ºÖÐÐÔÖ¬·¾£¨¸ÊÓÍÈýÖ¬£©Ðî»ýÓÚ·ÇÖ¬·¾Ï¸°ûµÄϸ°ûÖÊÖгÆΪ֬·¾±ä£¬¶à·¢ÉúÓÚ¸Îϸ°û¡¢Ðļ¡Ï¸°û¡¢ÉöС¹ÜÉÏƤϸ°ûµÈ¡£ 7Wd}H Z
10£® »¢°ßÐÄ£ºÐļ¡Ö¬·¾±äʱ£¬Ö¬·¾±äµÄÐļ¡³Ê»ÆÉ«£¬ÓëδÊÜÇÖ·¸µÄºìÉ«Ðļ¡Ïà¼äÅÅÁУ¬ÐγÉ×´ËÆ»¢Æ¤µÄ°ßÎÆ£¬³ÆΪ¡°»¢°ßÐÄ¡±¡£ cqP)1V]
11£® Ðļ¡Ö¬·¾½þÈó£¨fatty infiltration£©£ºÖ¸ÐÄÍâĤÏÂÓйý¶àµÄÖ¬·¾²¢ÏòÐļ¡ÄÚÉìÈ룬Ðļ¡ÒòÊÜÉìÈëÖ¬·¾×éÖ¯µÄ¼·Ñ¹¶øήËõ²¢ÏÔ±¡Èõ£¬³ÆΪÐļ¡Ö¬·¾½þÈó¡£¼ûÓڸ߶ȷÊÅÖÕß»òÒûÆ¡¾Æ¹ý¶ÈÕߣ¬´ó¶àÎÞÃ÷ÏÔÖ¢×´£¬ÑÏÖØʱ¿ÉÒòÐÄË¥¶øâ§ËÀ¡£ TLBIM
12£® »ÆÉ«Áö£ºÍÌÊÉ´óÁ¿µ¨¹Ì´¼µÄ¾ÞÊÉϸ°û°ûÖʳÊÅÝÄ×´¡£ÕâЩϸ°û¿É³ÉÍųöÏÖÓÚƤÏ£¬ÐγÉÁöÑùÖ×Î³ÆΪ»ÆÉ«Áö¡£ j. @CB`
13£® RussellСÌ壺½¬Ï¸°ûºÏ³ÉµÄÃâÒßÇòµ°°×»ý¾ÛÔÚÄÚÖÊÍøÖУ¬Ê¹ÄÚÖÊÍøÃ÷ÏÔÀ©ÕÅÐγɴóµÄ¾ùÖʵÄÊÈËáÐÔ°üºÌ壬³ÆΪRussellСÌå¡£ \Vc-W|e
14£® µí·ÛÑù±ä£¨amyloid change£©£ºÊÇָϸ°ûÍâ¼äÖÊÄÚ³öÏÖµí·ÛÑùµ°°×µÄÒì³£³Á»ý¡£µí·ÛÑùÎïÖÊΪ½áºÏÕ³¶àÌǵĵ°°×ÖÊ£¬Óöµâʱ±»È¾³É³àºÖÉ«£¬ÔÙÓöÁòËáÔò³ÊÀ¶É«£¬Óëµí·ÛÓöµâµÄ·´Ó¦ÏàËÆ£¬¹Ê´ËµÃÃûΪµí·ÛÑùÎïÖÊ¡£HEÇÐƬÉϾµÏÂÌصãΪµºìÉ«¾ùÖÊ×´Îï³Á»ý£¬³£¼ûÓÚϸ°û¼ä¡¢Ð¡Ñª¹Ü»ùµ×ĤÏ»òÑØÍø×´ÏËά֧¼Ü·Ö²¼¡£ 8uj;RG
15£® ²£Á§Ñù±ä£ºÏ¸°û»ò¼äÖÊÖгöÏÖHEȾɫΪ¾ùÖÊÊÈÒÁºìȾ°ë͸Ã÷×´µÄµ°°×ÖÊÐî»ý³ÆΪ²£Á§Ñù±ä£¬»ò³Æ͸Ã÷±ä£¨hyaline degeneration£©.·ÖΪϸ°ûÄÚ²£Á§Ñù±ä¡¢ÏËά½áµÞ×éÖ¯²£Á§Ñù±äºÍϸ¶¯Âö±Ú²£Á§Ñù±ä¡£ v;S_7#
16£® Õ³ÒºÑù±ä£¨mucoid degeneration£©£ºÊÇÖ¸¼äÖÊÄÚÓÐÕ³¶àÌǺ͵°°×ÖʵÄÐî»ý¡£³£¼ûÓÚ¼äÒ¶×éÖ¯Ö×Áö¡¢·çʪ²¡¡¢¶¯ÂöÖàÑùÓ²»¯µÈ¡£¾µÏ£º¼äÖÊÊèËÉ£¬ÓжàÍ»ÆðµÄÐÇâ״ÏËάϸ°ûÉ¢ÔÚÓÚ»ÒÀ¶É«Õ³ÒºÑùµÄ»ùÖÊÖС£ Dz<"eyB\
17£® Ö¬ºÖËØ£¨lipofuscin£©£ºÊÇϸ°û×ÔÊÉÈÜøÌåÄÚδ±»Ïû»¯µÄϸ°ûÆ÷ËéƬ²ÐÌå¡£Ö¬ºÖËØÖ»´ú±í×ÔÓÉ»ùËðÉ˺ÍÖ¬ÖʹýÑõ»¯µÄ½á¹û£¬Í¨³£¼ûÓÚÀÏÄêÈË¡¢ÓªÑø²»Á¼ºÍÂýÐÔÏûºÄÐÔ²¡È˵ĸÎϸ°û¡¢Ðļ¡Ï¸°ûºÍÉñ¾ÔªÄÚ£¬¹ÊÓÐÀÏÄêÐÔ¼¤ËغÍÏûºÄÐÔ¼¤ËØÖ®³Æ¡£ f!|$!r*q
18£® º¬ÌúѪ»ÆËØ£¨hemosiderin£©£ºÊÇѪºìµ°°×´úлµÄÑÜÉúÎºìϸ°û»òѪºìµ°°×±»¾ÞÊÉϸ°ûÍÌÊɺó£¬Í¨¹ýÈÜøÌåµÄÏû»¯£¬À´×ÔѪºìµ°°×µÄFe3+Óëµ°°×Ðγɵ羵Ï¿ɼûµÄÌúµ°°×΢Á££¬Èô¸ÉÌúµ°°×΢Á£¾Û¼¯³ÉΪ¹â¾µÏ¿ɼûµÄ´óС²»Ò»µÄ½ð»ÆÉ«»ò×Ø»ÆÉ«¿ÅÁ££¬¾ßÓÐÕÛ¹âÐÔ¡£º¬ÌúѪ»ÆËØͨ³£¼ûÓÚ¹ÇËè¡¢¸Î¡¢Æ¢µÄ¾ÞÊÉϸ°ûÄÚ¡£ÆÕ³ʿÀ¼·´Ó¦³ÉÀ¶É«¡£ P^wDt14>
19£® ÐÄ˥ϸ°û£º³¤ÆÚ·´¸´·¢×÷µÄÐÄÁ¦Ë¥½ß»¼Õߣ¬Òò·ÎÄÚ³ÖÐø³äѪ£¬Â©³öµÄ»òÒòëϸѪ¹ÜÆÆÁѳöѪµÄºìϸ°û±»·ÎÄÚ¾ÞÊÉϸ°ûÍÌÊÉ£¬È»ºóÒÔº¬ÌúѪ»ÆËØÐÎʽ³Á»ýÏÂÀ´¡£ÕâÀà³öÏÖÓÚ×óÐÄË¥»¼Õß·ÎÄÚºÍ̵Äڵĺ¬Óк¬ÌúѪ»ÆËصľÞÊÉϸ°û³ÆΪÐÄÁ¦Ë¥½ßϸ°û¡£ E
%A] 8y7
20£® ²¡ÀíÐԸƻ¯£¨pathologic calcification£©£ºÔڹǺÍÑÀÒÔÍâµÄ×éÖ¯ÄÚÓйÌÌåµÄ¸ÆÑγÁ»ý³ÆΪ²¡ÀíÐԸƻ¯¡£ hkifd4#
21£® ÓªÑø²»Á¼ÐԸƻ¯£¨dystrophic calcification£©£ºÖ¸¼Ì·¢ÓÚ¾Ö²¿×éÖ¯»µËÀºÍÒìÎïµÄÒì³£¸ÆÑγÁ»ý£¬¿É¼ûÓÚ½áºË»µËÀÔî¡¢Ö¬·¾»µËÀÔî¡¢¶¯ÂöÖàÑùÓ²»¯Ð԰߿顢Ѫ˨µÈ¡£ scXY~l]I*
22£® תÒÆÐԸƻ¯£¨metastatic calcification£©£ºÖ¸È«ÉíÐÔ¸ÆÁ×´úлÕÏ°£¬Ñª¸ÆºÍѪÁ×Ôö¸ßËùÒýÆðµÄijЩ×éÖ¯µÄ¸ÆÑγÁ»ý¡£¿É¼ûÓÚ¼××´ÅÔÏÙ¹¦ÄÜ¿º½ø¡¢Î¬ÉúËØD¹ý¶àÖ¢µÈ¡£×ªÒÆÐԸƻ¯¸ÆÑγ£³Á»ýÓÚÕý³£ÃÚËáµÄ²¿Î»£¬Èç·ÎÅݱڡ¢ÉöС¹Ü»ùµ×ĤºÍθճĤÉÏƤ¡£ oS2L"#
23£® »µËÀ£¨necrosis£©£ºÊÇ»îÌåÄÚ¾Ö²¿×éÖ¯¡¢Ï¸°ûµÄËÀÍö¡£»µËÀºóµÄϸ°ûºÍ×éÖ¯²»½ö´úлֹͣ¡¢¹¦ÄÜɥʧ£¬¶øÇÒϸ°ûÄÚÎïÖʵÄÉø³ö£¬ÒýÆðÖÜΧ×éÖ¯µÄÑ×Ö¢·´Ó¦¡£¿ÉÓÉ×ÔÈÜ»òÒìÈÜÒýÆð¡£ EAPLe{qw:q
24£® ºË¹ÌËõ£¨pyknosis£©£ºÓÉÓÚ»µËÀϸ°ûºËË®·ÖÍÑʧ£¬È¾É«ÖÊÄý¾Û£¬Ï¸°ûºË±äС£¬ÊȼîÐÔÔöÇ¿£¬³ÆºË¹ÌËõ¡£ OA_WjTwDs
25£® ºËËéÁÑ£¨karyorrhexis£©£ºÏ¸°ûºËÓÉÓÚºËȾɫÖʱÀ½âºÍºËĤËéÁѶø·¢ÉúËéÁÑ£¬¿ÉÓɺ˹ÌËõËéÁѳÉËéƬ¶øÀ´¡£ bgi
B*`z
26£® ºËÈܽ⣨karyolysis£©£ºÓÉ·ÇÌØÒìÐÔDNAøºÍµ°°×ø¼¤»î·Ö½âºËDNAºÍºËµ°°×ËùÖ£¬ºËȾɫÖÊÊȼîÐÔϽµ£¬ËÀÍöϸ°ûºËÔÚ1-2ÌìÄÚÍêÈ«Ïûʧ¡£ Ys+2/>!
27£® Äý¹ÌÐÔ»µËÀ£¨coagulative necrosis£©£ºµ°°×ÖÊ·¢ÉúÄý¹ÌÇÒÈÜøÌåøˮ½â×÷ÓýÏÈõʱ£¬»µËÀÇø³Ê»Ò»Æ¡¢¸ÉÔï¡¢ÖÊʵ״̬£¬³ÆΪÄý¹ÌÐÔ»µËÀ¡£¶à¼ûÓÚÐÄ¡¢¸Î¡¢Éö¡¢Æ¢µÈÆ÷¹Ù£¬´ËÖÖ»µËÀÓ뽡¿µ×éÖ¯¼ä½çÏÞ¶àÃ÷ÏÔ£¬¾µÏÂÌصãΪϸ°û½á¹¹Ïûʧ£¬¶ø×éÖ¯ÂÖÀªÉд档 /o$C=fDF
28£® Òº»¯ÐÔ»µËÀ£¨liquefactive necrosis£©£ºÓÉÓÚ»µËÀ×éÖ¯ÖпÉÄý¹ÌµÄµ°°×ÖÊÉÙ£¬»ò»µËÀϸ°û×ÔÉí¼°½þÈóµÄÖÐÐÔÁ£Ï¸°ûµÈÊÍ·Å´óÁ¿Ë®½âø£¬»ò×éÖ¯¸»º¬Ë®·ÖºÍÁ×Ö¬£¬Ôòϸ°û×éÖ¯ÈÝÒ×·¢ÉúÈܽâÒº»¯£¬³ÆΪҺ»¯ÐÔ»µËÀ¡£ E41ay:duAl
29£® ¸ÉÀÒÑù»µËÀ£¨caseous necrosis£©£ºÊÇÌØÊâÀàÐ͵ÄÄý¹ÌÐÔ»µËÀ¡£ÈâÑÛ¹Û΢»Æ£¬ÖÊËÉÈí¡¢Ï¸Ä壬״ËƸÉÀÒ¶øµÃÃû¡£Ö÷Òª¼ûÓÚ½áºË²¡¡£¾µÏÂÔÓеÄ×éÖ¯½á¹¹ÍêÈ«±À½âÆÆ»µ£¬³ÊÏÖһƬÎÞ¶¨ÐΡ¢¿ÅÁ£×´µÄºìȾÎï¡£ l\Q--
30£® »µ¾Ò£*****angrene£©£ºÊÇÖ¸×éÖ¯»µËÀ²¢¼Ì·¢¸¯°Ü¾ú¸ÐȾ¡£³£·¢ÉúÔÚÖ«Ìå»òÓëÍâ½çÏàͨµÄÄÚÔà¡£·ÖΪ¸ÉÐÔ»µ¾Ò¡¢ÊªÐÔ»µ¾ÒºÍÆøÐÔ»µ¾Ò¡£ v;%>F)I
31£® Ö¬·¾»µËÀ£¨fat necrosis£©£ºÖ÷ÒªÓÐø½âÐÔÖ¬·¾»µËÀºÍÍâÉËÐÔÖ¬·¾»µËÀÁ½ÖÖ¡£Ç°Õß³£¼ûÓÚ¼±ÐÔÒÈÏÙÑ×ʱÒÈøÍâÒç²¢¼¤»î£¬ÍâÉËÐÔÖ¬·¾»µËÀ´ó¶à¼ûÓÚÈéÏÙÍâÉË¡£ L0sb[:'luz
32£® ÏËάËØÑù»µËÀ£¨fibrinoid necrosis£©£ºÊÇ·¢ÉúÓÚÏËά½áµÞ×éÖ¯ºÍѪ¹Ü±ÚµÄÒ»ÖÖ»µËÀ¡£²¡±ä¾Ö²¿×éÖ¯½á¹¹Ïûʧ£¬Ðγɱ߽粻ÇåµÄСÌõ»òС¿é״ȾɫÉîºìµÄ£¬ÓÐÕÛ¹âÐÔµÄÎ޽ṹÎïÖÊ¡£ÓÉÓÚÆäȾɫÐÔÖÊÓëÏËάËØÏàËÆ£¬¹Ê¶øµÃÃû¡£ ZxDh94w/
33£® ÃÓÀã¨erosion£©£ºÆ¤·ô¡¢Õ³Ä¤´¦µÄdz±íÐÔ»µËÀÐÔȱËð³ÆΪÃÓÀà u3[A~V|0=
34. À£Ññ£¨ulcer£©£ºÆ¤·ô¡¢Õ³Ä¤´¦µÄ½ÏÉîµÄ»µËÀÐÔȱËð³ÆΪÀ£Ññ¡£ =>y%Aj&4
33£® ñ¼µÀ£¨sinus£©£¬ðü¹Ü(fistula)£º×éÖ¯»µËÀºóÐγɵĿª¿ÚÓÚƤ·ôճĤ±íÃæµÄÉîÔÚÐÔä¹Ü³ÆΪñ¼µÀ£¬Á½¶Ë¿ª¿ÚµÄͨµÀÑùȱËð³ÆΪðü¹Ü¡£ s-S#qGZ
34£® ¿Õ¶´£¨cavity£©£ºÉö¡¢·ÎµÈÆ÷¹ÙµÄ»µËÀ×éÖ¯Òº»¯ºó¿É¾×ÔÈ»¹ÜµÀ£¨ÊäÄò¹Ü¡¢Æø¹Ü£©Åųö£¬ÁôϵĿÕÇ»³ÆΪ¿Õ¶´¡£ 4!l%@R>O2
35£® »ú»¯(organization):»µËÀ×éÖ¯²»ÄÜÍêÈ«ÈܽâÎüÊÕ»ò·ÖÀëÅųö£¬ÔòÓÉÈâÑ¿×éÖ¯³¤È벢ȡ´ú»µËÀ×éÖ¯¡¢ÑªË¨¡¢ÒìÎïµÈµÄ¹ý³Ì£¬³ÆΪ»ú»¯£¬×îÖÕÐγÉñ£ºÛ×éÖ¯¡£ %^zGM^PD
36£® °ü¹ü£¨encapsulation£©£ºÈç¹û»µËÀÔî½Ï´ó£¬»ò»µËÀÎïÖÊÄÑÓÚÈܽâÎüÊÕ£¬»ò²»ÄÜÍêÈ«»ú»¯£¬Ôò³£ÓÉÈâÑ¿×éÖ¯¼ÓÒÔ°ü¹ü£¬ÒÔºóÔòΪÔöÉúµÄÏËά×éÖ¯°ü¹ü¡£ y3^>a5z!x
37£® µòÍö£¨apoptosis£©£ºÊÇÓÉÌåÄÚÍâijЩÒòËØ´¥·¢Ï¸°ûÄÚÔ¤´æµÄËÀÍö³ÌÐò¶øµ¼ÖµÄϸ°ûµÄÖ÷¶¯ÐÔËÀÍö·½Ê½£¬Ò»°ãΪµ¥¸öϸ°ûµÄËÀÍö£¬²»ÒýÆðÖÜΧ×éÖ¯µÄÑ×Ö¢¡£Ò»°ãÎÄÏ׳Æ֮Ϊ³ÌÐòÐÔϸ°ûËÀÍö¡£ v`G [6Z
38£® µòÍöСÌ壨apoptotic bodies£©: ϸ°ûµòÍöʱ£¬µòÍöµÄϸ°ûÖåËõ£¬µ«Ï¸°ûĤÍêÕû£¬ºóϸ°ûĤÏÂÏÝ£¬°ü¹üºËËéƬºÍϸ°ûÆ÷£¬ÐγɵòÍöСÌå¡£È粡¶¾ÐÔ¸ÎÑ×ʱµÄCouncilmanСÌå¡£ KKFV+bK)
39£® MalloryСÌ壺¾Æ¾«ÐԸβ¡Ê±£¬¸Îϸ°û°ûÖÊÖÐϸ°ûÖмäË¿Ç°½Çµ°°×±äÐÔËùÐγɣ¬±íÏÖΪ¸Îϸ°û°û½¬ÄÚ¾ùÖʺìȾµÄÔ²ÐÎСÌå¡£ `A\|qH5`W
40£® ±äÐÔ£¨degeneration£©£ºÓֳƿÉÄæÐÔËðÉË£¬ÊÇָϸ°û»òϸ°û¼äÖÊÊÜËðÉ˺ó£¬Ï¸°û»òϸ°û¼äÖÊÄÚ³öÏÖÒì³£ÎïÖÊ»òÕý³£ÎïÖÊÒì³£Ðî»ýµÄÏÖÏó¡£³£°éÓй¦ÄÜϽµ¡£ 1kX>sajp~
41£® ÐÞ¸´£¨repair£©£ºËðÉËÔì³É»úÌ岿·Öϸ°ûºÍ×é֯ɥʧºó£¬»úÌå¶ÔËùÐγÉȱËð½øÐÐÐÞ²¹»Ö¸´µÄ¹ý³Ì£¬³ÆΪÐÞ¸´¡£ (E*pM$
42£® ÔÙÉú£¨regeneration£©£º×éÖ¯ËðÉ˺óÓÉËðÉËÖÜΧµÄͬÖÖϸ°ûÀ´ÐÞ¸´£¬³ÆΪÔÙÉú£¬·ÖΪÍêÈ«ÔÙÉúºÍ²»ÍêÈ«ÔÙÉú¡£ dPVl\<L1
43£® ²»Îȶ¨Ï¸°û£¨labile cell£©£ºÓֳƳÖÐø·ÖÁÑϸ°û¡£ÕâÀàϸ°û×ÜÊÇÔÚ²»¶ÏµÄÔöÖ³£¬ÒÔ´úÌæË¥Íö»òÆÆ»µµÄϸ°û£¬Èç±íƤϸ°û¡¢ºôÎüµÀºÍÏû»¯µÀճĤ±»¸²Ï¸°û¡¢ÄÐÐÔ¼°Å®ÐÔÉúÖ³Æ÷¹Ù¹ÜÇ»µÄ±»¸²Ï¸°ûµÈ£¬ÕâЩϸ°ûµÄÔÙÉúÄÜÁ¦ºÜÇ¿¡£ UtpK"U$XOU
44£® Îȶ¨Ï¸°û£¨stable cell£©£ºÓֳƾ²Ö¹Ï¸°û¡£ÔÚÉúÀíÇé¿öÏ£¬ÕâÀàϸ°ûÔöÖ³ÏÖÏó²»Ã÷ÏÔ£¬ÔÚϸ°ûÖÜÆÚÖд¦ÓÚ¾²Ö¹ÆÚ£*****0£©£¬µ«Êܵ½×éÖ¯ËðÉ˵Ĵ̼¤ºó£¬Ôò½øÈëDNAºÏ³ÉÆÚ£*****1£©£¬±íÏÖ³ö½ÏÇ¿µÄÔÙÉúÄÜÁ¦¡£ÕâÀàϸ°û°üÀ¨¸÷ÖÖÏÙÌå»òÏÙÑùÆ÷¹ÙµÄʵÖÊϸ°û£¬Èç¸Î¡¢ÒÈ¡¢ÏÑÏٵȣ¬»¹°üÀ¨ÔʼµÄ¼äҶϸ°û¼°Æä·Ö»¯³öÀ´µÄ¸÷ÖÖϸ°û¡£ (mR;MC
45£® ÓÀ¾ÃÐÔϸ°û£¨permanent cell£©£ºÊôÓÚÕâÀàϸ°ûµÄÓÐÉñ¾Ï¸°û¡¢¹Ç÷À¼¡Ï¸°û¡¢Ðļ¡Ï¸°û¡£ÎÞÂÛÖÐÊàÉñ¾Ï¸°û¼°ÆäÖÜΧÉñ¾µÄÉñ¾½Úϸ°û£¬³öÉúºó¶¼²»ÄÜ·ÖÁÑÔöÉú£¬Ò»µ©ÔâÊÜÆÆ»µÔò³ÉΪÓÀ¾ÃÐÔȱʧ¡£µ«Õâ²»°üÀ¨Éñ¾ÏËά£¬ÔÚÉñ¾Ï¸°û´æ»îµÄÇ°ÌáÏÂÊÜËðµÄÉñ¾ÏËάÓÐ×Å»îÔ¾µÄÔÙÉúÄÜÁ¦¡£ 1(nK |
46£® ´´ÉËÐÔÉñ¾Áö£ºÍâÖÜÉñ¾ÊÜËðʱ£¬Èô¶ÏÀëµÄÁ½¶ËÏà¸ôÌ«Ô¶£¬»òÕßÁ½¶ËÖ®¼äÓÐñ£ºÛ»òÆäËû×éÖ¯×è¸ô£¬»òÕßÒò½Ø֫ʧȥԶ¶Ë£¬ÔÙÉúÖáÍ»²»Äܵ½´ïÔ¶¶Ë£¬¶øÓëÔöÉúµÄ½áµÞ×éÖ¯»ìÔÓÔÚÒ»Æ𣬾íÇú³ÉÍÅ£¬³ÉΪ´´ÉËÐÔÉñ¾Áö£¬¿É·¢ÉúÍç¹ÌÐÔÌÛÍ´¡£ ~T'!.^/
47£® ϸ°ûÍâ»ùÖÊ£¨extracellular matrix£¬ECM£©£ºÔÚÈκÎ×éÖ¯¶¼Õ¼ÓÐÏ൱±ÈÀý£¬ËüµÄÖ÷Òª×÷ÓÃÊÇ°Ñϸ°ûÁ¬½ÓÔÚÒ»Æ𣬽èÒÔÖ§³ÅºÍά³Ö×éÖ¯µÄÉúÀí½á¹¹ºÍ¹¦ÄÜ¡£Ö÷Òª³É·ÖÓнºÔµ°°×¡¢µ¯Á¦µ°°×¡¢Õ³Á¬Ìǵ°°×¡£ &_V
d
48£® ÈâÑ¿×éÖ¯£*****ranulation tissue£©£ºÓÉÐÂÉú±¡±ÚµÄëϸѪ¹ÜÒÔ¼°ÔöÉúµÄ³ÉÏËάϸ°û¹¹³É£¬²¢°éÓÐÑ×ÐÔϸ°û½þÈó£¬ÈâÑÛ±íÏÖΪÏʺìÉ«£¬¿ÅÁ£×´£¬ÈáÈíʪÈó£¬ÐÎËÆÏÊÄÛµÄÈâÑ¿¹Ê¶øµÃÃû¡£ >3,t`Z:
49£® ñ£ºÛ×éÖ¯£ºÊÇÖ¸ÈâÑ¿×éÖ¯¾¸Ä½¨³ÉÊìÐγɵÄÏËά½áµÞ×éÖ¯£¬´Ëʱ×éÖ¯ÓÉ´óÁ¿Æ½Ðлò½»´í·Ö²¼µÄ½ºÔÏËάÊø×é³É¡£ xGBp+j1H
50£® ñ£ºÛ¸í´ñ£¨keloid£©£ºñ£ºÛ×éÖ¯ÔöÉú¹ý¶ÈÍ»³öÓÚƤ·ô±íÃæ²¢ÏòÖÜΧ²»¹æÔòÀ©ÑÓ£¬³ÆΪñ£ºÛ¸í´ñ¡£